World Thrombosis Day
With one of the largest portfolios of hemostasis-specific tests and systems dedicated to the diagnosis of blood-clotting disorders, Siemens Healthineers supports clinicians in the fight against one of the biggest health threats to our communities. Our commitment goes beyond providing clinicians with the diagnostic solutions they need—which is why we are proud to sponsor the annual World Thrombosis Day in an effort to promote thrombosis risk education and ultimately save lives.
World Thrombosis Day
World Thrombosis Day (WTD) is an initiative spearheaded by the International Society on Thrombosis and Hemostasis (ISTH) to raise awareness about the prevalence of blood clots and the actions individuals can take to mitigate their risk of this disease. WTD supports the World Health Assembly’s global target of reducing premature deaths due to non-communicable disease by 25% by 2025.
While thrombosis is the primary factor behind the three leading causes of cardiovascular death—heart attack, stroke, and venous thromboembolism (VTE)—the initial launch of WTD will emphasize prevention of VTE (responsible for an estimated 600,000–800,000 deaths in the U.S. and Europe each year1,2). However, over time WTD will expand its focus to address all thrombotic disorders.
Thrombosis is a blood clot that forms in any artery or vein. It is the underlying cause of the world's top three cardiovascular killers: heart attack, stroke, and venous thromboembolism (VTE), a blood clot found mostly in the legs and lungs.
More than two–thirds of blood clots in the leg result from being in the hospital, which is the leading cause of preventable deaths.3 Furthermore, certain surgeries, including hip and knee and surgeries for cancer, put a patient at higher risk.
Siemens Healthcare Diagnostics employs approximately 14,000 employees worldwide and operates around the globe; with three decades of experience in hemostasis testing, Siemens seeks to leverage its extensive knowledge and resources to promote WTD at a local and global level. Having cultivated relationships with numerous hospitals, laboratories, and clinicians around the world, Siemens finds itself in a unique position to help raise thrombosis-risk awareness for both healthcare professionals and the general public.
To learn more about our complete hemostasis product portfolio.
1Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007 Oct;98(4):756-64.
2Heit J, Cohen A, Anderson F. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US. Blood. 2005;106:267A.
3Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism. American Journal of Preventive Medicine. 2010;38(4):S495-S501.
*This white paper provides additional information. Siemens is only responsible for claims as provided in the Instructions for Use. It is the responsibility of the user to validate any modifications made to product claims as provided in the Instructions for Use.